Organisation
Basic (bio-) Medical Sciences
Department
Basic and applied biomedical research, and biomedical science-based higher education.
Current researchers
81 - 90 of 155 results
- Hediel Madhloum (Member)
- Samuel Madureira Silva (Member)
- Ken Maes (Member)
- Debanjana Majumdar (Member)
- Myrthe Mampay (Member)
- Inge Mannaerts (Member)
- Marta Marco Aragon (Member)
- Ken Matsumoto (Member)
- Fien Meeus (Member)
- Eline Menu (Member)
Projects
81 - 90 of 141
- The search for the origin of chromosomal abnormalities in human preimplantation embryosFrom1 Oct 2019 → 31 Oct 2023Funding: FWO fellowships
- DohART-net: Periconceptional Programming of Health Training NetworkFrom1 Jul 2019 → 30 Sep 2023Funding: H2020-EU.1.3.- EXCELLEN SCIENCE - Marie Skłodowska-Curie actions
- SRP-Groeifinanciering: Molecular Portrait of Pancreatic Tumours: Veni, vidi, viciFrom1 Mar 2019 → TodayFunding: BOF - projects
- Development of a NanoCAR-T cell approach for the treatment of multiple myelomaFrom1 Jan 2019 → 31 Dec 2023Funding: FWO fellowships
- Acinar cell specific susceptibility for tumor development in the pancreas: target the critical regulators for therapyFrom1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- RNAct: Enabling proteins with RNA recognition motifs for synthetic biology and bio-analytics.From1 Jan 2019 → 31 Dec 2022Funding: H2020-EU.1.3.- EXCELLEN SCIENCE - Marie Skłodowska-Curie actions
- CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular DiseaseFrom1 Jan 2019 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Enhancing the immunogenicity and antitumor efficacy of virotherapy by supplementing an oncolytic virus with checkpoint inhibition and immunological cell death inducersFrom1 Jan 2019 → 31 Dec 2022Funding: FWO fellowships
- RNAct: Enabling proteins with RNA recognition motifs for synthetic biology and bio-analytics (OZR Bonus EU)From1 Jan 2019 → 31 Dec 2022Funding: University - Project driven research
- Smart design nanoParticles to Activate immune Responses against Cancer (SPARC)From1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 1112
- Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone
Authors: Tilmann Bochtler, Ute Hegenbart, Christina Kunz, Axel Benner, Anja Seckinger, Sascha Dietrich, Martin Granzow, Kai Neben, Hartmut Goldschmidt, Anthony D Ho, et al.
Pages: 9-17 - Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens
Authors: Tilmann Bochtler, Ute Hegenbart, Christina Kunz, Martin Granzow, Axel Benner, Anja Seckinger, Christoph R Kimmich, Hartmut Goldschmidt, Anthony D Ho, Dirk Hose, et al.
Pages: 1371-1378 - Hoxb1 Regulates Distinct Signaling Pathways in Neuromesodermal and Hindbrain Progenitors to Promote Cell Survival and Specification
Authors: Kristijan Pazur, Ioannis Giannios, Mathias Lesche, Eva Rodriguez-Aznar, Anthony Gavalas
Pages: 175-189 - CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma
Authors: Elina Alaterre, Sebastien Raimbault, Hartmut Goldschmidt, Salahedine Bouhya, Guilhem Requirand, Nicolas Robert, Stéphanie Boireau, Anja Seckinger, Dirk Hose, Bernard Klein, et al.
Pages: 98931-98944 - Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro
Authors: Isabelle Krämer, Melanie Engelhardt, Sabrina Fichtner, Brigitte Neuber, Sergej Medenhoff, Uta Bertsch, Jens Hillengass, Marc-Steffen Raab, Dirk Hose, Anthony D Ho, et al.
- Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment
Authors: Anja Seckinger, Jose Antonio Delgado, Samuel Moser, Laura Moreno, Brigitte Neuber, Anna Luise Grab, Susanne Lipp, Juana Merino, Felipe Prosper, Martina Emde-Rajaratnam, et al.
Pages: 396-410 - Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma
Authors: Elena Viziteu, Camille Grandmougin, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, Bernard Klein, Jerome Moreaux
Pages: 519-523 - A tissue-based approach to selection of reference genes for quantitative real-time PCR in a sheep osteoporosis model
Authors: Felix Schulze, Deeksha Malhan, Thaqif El Khassawna, Christian Heiss, Anja Seckinger, Dirk Hose, Angela Rösen-Wolff
- Drug Release as a function of bioactivity, incubation regime, liquid, and initial load
Authors: Benjamin Kruppke, Dirk Hose, Reinhard Schnettler, Anja Seckinger, Sina Rößler, Thomas Hanke, Sascha Heinemann
Pages: 1165-1173 - GenomicScape
Authors: Alboukadel Kassambara, Thierry Rème, Michel Jourdan, Thierry Fest, Dirk Hose, Karin Tarte, Bernard Klein